87.99
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CORT Giù?
Forum
Previsione
Corcept Therapeutics Inc Borsa (CORT) Ultime notizie
Assessing Corcept Therapeutics (CORT) Valuation as Relacorilant Nears Key PDUFA Decision and Analyst Optimism Builds - Yahoo Finance
Wall Street Firms Tout Corcept Therapeutics Incorporated (CORT) Prospects on Korlym Medication Prospects - Yahoo Finance
Analysts see 70% upside potential in Corcept Therapeutics (CORT) stock - MSN
Hsbc Holdings PLC Reduces Stock Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics Incorporated $CORT Shares Sold by American Century Companies Inc. - MarketBeat
Epoch Investment Partners Inc. Invests $56.18 Million in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept, Optime file reply for dismissing Teva's US antitrust claims - MLex
Kennedy Capital Management LLC Raises Stake in Corcept Therapeutics Incorporated $CORT - MarketBeat
Norges Bank Makes New Investment in Corcept Therapeutics Incorporated $CORT - MarketBeat
State Board of Administration of Florida Retirement System Has $4.30 Million Stock Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Is Corcept Therapeutics Incorporated (HTD) stock a buy before new product rolloutEarnings Performance Report & Weekly High Return Stock Forecasts - Newser
Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Insider Sells 20,000 Shares of Stock - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Insider Sean Maduck Sells 20,000 Shares - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Insider Sells $397,650.00 in Stock - MarketBeat
Will Corcept Therapeutics Incorporated (HTD) stock return to pre crash levelsMarket Volume Report & Free High Accuracy Swing Entry Alerts - Newser
Corcept (CORT) Up 9.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Chief Development Officer At Corcept Therapeutics Sells $364K Of Stock - Benzinga
Is Corcept Therapeutics Incorporated (HTD) stock inflation resilient2025 Momentum Check & Fast Moving Stock Trade Plans - Newser
Shelton Capital Management Sells 125,365 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Bridge City Capital LLC Sells 22,487 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics Insider Sold Shares Worth $1,590,490, According to a Recent SEC Filing - marketscreener.com
Corcept Therapeutics Insider Sold Shares Worth $3,190,796, According to a Recent SEC Filing - MarketScreener
Lyon of Corcept Therapeutics sells $397k in shares By Investing.com - Investing.com South Africa
Corcept Therapeutics exec William Guyer sells $1.6m in shares By Investing.com - Investing.com Canada
Officer Guyer Sells 20,000 ($1.6M) Of Corcept Therapeutics Inc [CORT] - TradingView
Lyon of Corcept Therapeutics sells $397k in shares - Investing.com
Corcept Therapeutics CEO Belanoff sells $3.19 million in stock By Investing.com - Investing.com Canada
Van Hulzen Asset Management LLC Purchases New Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
3 Growth Companies With High Insider Ownership Seeing 30% Revenue Growth - simplywall.st
Russell Investments Group Ltd. Has $13.67 Million Stake in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics Incorporated $CORT Shares Sold by SG Americas Securities LLC - MarketBeat
Officer Guyer Files To Sell 20,000 Of Corcept Therapeutics Inc [CORT] - TradingView
Corcept Therapeutics (CORT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Will Corcept Therapeutics Incorporated (HTD) stock outperform global peers - Newser
Is Corcept Therapeutics Incorporated (HTD) stock undervalued at current priceMarket Risk Analysis & Low Risk Investment Opportunities - Newser
Will Korlym Continue to Drive Corcept's Top Line in 2026? - Yahoo Finance
Corcept Therapeutics Incorporated $CORT Shares Sold by Rhumbline Advisers - MarketBeat
F m Investments LLC Invests $1.61 Million in Corcept Therapeutics Incorporated $CORT - MarketBeat
Capital Fund Management S.A. Trims Stock Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
19,858 Shares in Corcept Therapeutics Incorporated $CORT Acquired by XTX Topco Ltd - MarketBeat
Cushing’s Syndrome Diagnostics and Therapeutics Market, 2034 - Global Market Insights Inc.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Is Largely Controlled by Institutional Shareholders Who Own 69% of the Company - 富途牛牛
Legal & General Group Plc Boosts Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Zacks Research Analysts Decrease Earnings Estimates for CORT - MarketBeat
Franklin Resources Inc. Increases Stock Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept (CORT) Q3 2025 Earnings Call Transcript - The Globe and Mail
Corcept Therapeutics (NASDAQ:CORT) Insider Sells $364,050.00 in Stock - MarketBeat
Whale Trades: Will Corcept Therapeutics Incorporated stock deliver strong dividend growthJuly 2025 Chart Watch & Expert Approved Trade Ideas - moha.gov.vn
Chief Development Officer Of Corcept Therapeutics Sold $364K In Stock - Benzinga
What is Zacks Research's Forecast for CORT FY2025 Earnings? - MarketBeat
Corcept Therapeutics Incorporat (CORT) Stock Forecasts - Yahoo Finance
Aug PreEarnings: Can Corcept Therapeutics Incorporated stock sustain free cash flow growth2025 Breakouts & Breakdowns & AI Powered Trade Plan Recommendations - BỘ NỘI VỤ
Insider Sell: William Guyer Sells Shares of Corcept Therapeutics Inc (CORT) - GuruFocus
CORCEPT THERAPEUTICS' Chief Development Officer Sells Shares - TradingView
Officer Guyer Sells 4,500 ($364.1K) Of Corcept Therapeutics Inc [CORT] - TradingView
Corcept Therapeutics Incorporated (CORT) Modifies Revenue Guidance while Banking on Cushing Syndrome Treatment for Growth - Finviz
CORCEPT THERAPEUTICS INC (1CORT.MI) - Yahoo! Finance Canada
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):